Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Press

Showing results (171-180 of 272) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experienceJ E Anderson, M R Litzow, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseaseO W Press, M LeBlanc, A S Lichter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphomaAjay K Gopal, Ted A Gooley, Joseph G Rajendran, et al.
Transplantation|November 1, 1992
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemiaF R Appelbaum, D C Matthews, J F Eary, et al.
Blood|February 17, 2007
Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomasAnastasia Pantelias, John M Pagel, Nathan Hedin, et al.
Blood|February 15, 1995
Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiationD C Matthews, F R Appelbaum, J F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1990
Imaging and treatment of B-cell lymphomaJ F Eary, O W Press, C C Badger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2018
Long-Term Follow-Up of <sup>90</sup>Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell LymphomaCamille E Puronen, Ryan D Cassaday, Philip A Stevenson, et al.
Blood|October 1, 1991
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaqueD C Matthews, F R Appelbaum, J F Eary, et al.
Cancer Research|May 1, 1996
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cellsO W Press, D Shan, J Howell-Clark, et al.
Pageof 28

Showing results (171-180 of 272) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experienceJ E Anderson, M R Litzow, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseaseO W Press, M LeBlanc, A S Lichter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphomaAjay K Gopal, Ted A Gooley, Joseph G Rajendran, et al.
Transplantation|November 1, 1992
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemiaF R Appelbaum, D C Matthews, J F Eary, et al.
Blood|February 17, 2007
Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomasAnastasia Pantelias, John M Pagel, Nathan Hedin, et al.
Blood|February 15, 1995
Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiationD C Matthews, F R Appelbaum, J F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1990
Imaging and treatment of B-cell lymphomaJ F Eary, O W Press, C C Badger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2018
Long-Term Follow-Up of <sup>90</sup>Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell LymphomaCamille E Puronen, Ryan D Cassaday, Philip A Stevenson, et al.
Blood|October 1, 1991
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaqueD C Matthews, F R Appelbaum, J F Eary, et al.
Cancer Research|May 1, 1996
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cellsO W Press, D Shan, J Howell-Clark, et al.
Pageof 28